|

Imatinib 400 MG Oral Tablet Clinical Trials

1 actively recruiting trial

Also known as: No other intervention

Top Sponsors

  • Vastra Gotaland Region1

Indications

  • Triple Negative Breast Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.